Cost-Effectiveness Analysis Of Neo-Adjuvant Pertuzumab Therapy In Women With Locally Advanced, Inflammatory, Or Early Her2-Positive Breast Cancer In Italy
Abstract
Authors
L Pradelli M Bellone S Era E Campagnoli
L Pradelli M Bellone S Era E Campagnoli
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now